Showing all 19 results
Desmopressin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extreme Microdose Peptide Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical stability of the fragile acetate salt.
Active Ingredient Strength Primary Clinical Function Desmopressin Acetate USP/Ph.Eur.
(Equivalent to Desmopressin base)0.1 mg The Titration & Pediatric Anchor: The definitive starting dose utilized for primary nocturnal enuresis in children or baseline control of Central Diabetes Insipidus. Desmopressin Acetate USP/Ph.Eur. 0.2 mg The Maintenance Macrodose: High-efficacy therapeutic payload utilized for severe, refractory polyuria and nocturia in adults. Excipients Lactose Monohydrate / Potato Starch / Povidone K-30 / Magnesium Stearate Diluent / Disintegrant / Binder / Lubricant (Engineered specifically utilizing Strict Geometric Dilution to ensure the microscopic peptide payload is flawlessly uniform, manufactured under stringent low-moisture conditions to prevent hydrolytic degradation of the fragile peptide bonds) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic endocrine dispensing regimens).
Ethinyestradiol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the synthetic steroidal API.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.05 mg (50 mcg) The Endocrinology Standard: The definitive micro-dose engineered specifically for female hypogonadism, primary ovarian failure, and strictly monitored estrogen replacement. Ethinylestradiol USP/Ph.Eur. 1 mg The Palliative Oncology Macrodose: Massive therapeutic payload utilized strictly for the aggressive hormonal suppression of advanced, inoperable prostate or breast cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the potent steroidal API, ensuring absolute safety for handlers and guaranteeing zero cross-contamination in the facility) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrine and oncology dispensing regimens).
Repaglinide and Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined formulation.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 1 mg / 2 mg Short-acting meglitinide for rapid post-prandial (after-meal) insulin stimulation. Metformin Hydrochloride USP/Ph.Eur. 500 mg Global Clinical Standard: Biguanide for hepatic glucose suppression and insulin sensitization. Excipients Microcrystalline Cellulose / Povidone K30 / Croscarmellose Sodium / Poloxamer / Magnesium Stearate Diluent / Binder / Superdisintegrant / Surfactant (Engineered for immediate gastric dissolution and synchronized dual-absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Repaglinide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly sensitive meglitinide API.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 0.5 mg Base titration unit for treatment-naive patients or those with severe renal/hepatic impairment. Repaglinide USP/Ph.Eur. 1 mg / 2 mg Global Clinical Standard: Advanced maintenance doses for rapid post-prandial insulin stimulation. Excipients Microcrystalline Cellulose / Calcium Hydrogen Phosphate / Meglumine / Poloxamer / Magnesium Stearate Diluent / Stabilizer / Surfactant / Lubricant (Engineered for immediate gastric dissolution and ultra-fast systemic absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Saxagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Saxagliptin (as Hydrochloride) INN/Ph.Eur. 2.5 mg Target dose for patients with moderate/severe renal impairment or those taking strong CYP3A4 inhibitors. Saxagliptin (as Hydrochloride) INN/Ph.Eur. 5 mg Global Clinical Standard: Maximum adult daily dose for the maintenance of Type 2 Diabetes. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Binder / Superdisintegrant (Engineered for immediate gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens).
Teneligliptin 20Mg + Metformin 500Mg Tablet Sustained Release
FreeAÂ Teneligliptin 20mg + Metformin 500mg Sustained Release (SR)Â tablet is a combination antidiabetic medication used to manage type 2 diabetes mellitus when diet and exercise alone are insufficient.
Teneligliptin Tablet
FreeA Teneligliptin 20mg tablet is a modern oral antidiabetic medication belonging to the DPP-4 inhibitor (dipeptidyl peptidase-4) class, used primarily to manage type 2 diabetes mellitus.
Vildagliptin & Metformin Tablet
FreeVildagliptin and Metformin combination tablets are fixed-dose oral anti-diabetic medications containing two active substances: Vildagliptin (a DPP-4 inhibitor) and Metformin Hydrochloride (a biguanide). These are primarily used to improve blood sugar control in adults with type 2 diabetes.
Vildagliptin Tablets
FreeVildagliptin tablets contain vildagliptin as the active ingredient, typically in a 50 mg strength. It is an oral anti-diabetic medication belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class, used to improve glycaemic control in adults with type 2 diabetes.
Voglibose & Metformin (SR) Tablets
FreeVoglibose and Metformin tablets typically contain Voglibose and Metformin Hydrochloride as the primary active ingredients. This combination is a standard treatment for type 2 diabetes mellitus to manage blood sugar levels.
Voglibose Tablet
FreeVoglibose tablets are oral anti-diabetic medications primarily composed of the active ingredient Voglibose, a synthetic alpha-glucosidase inhibitor. They are typically available in strengths of 0.2 mg or 0.3 mg.
